MarketCap
Facebook
X
TelegramAnnual report 2022
added 09-29-2022
Opthea Limited P/B Ratio 2011-2026 | OPT
Annual P/B Ratio Opthea Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 44 | 16.6 | 44.3 | - | 0.00958 | 0.0879 | 0.0182 | 0.00947 | 0.568 | 0.189 | 0.245 | 2.43 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.3 | 0.00947 | 9.85 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M |  USA |
 |
Veracyte
VCYT
|
2.32 | $ 30.92 | -5.73 % | $ 2.43 B | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | France |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
bluebird bio
BLUE
|
0.344 | - | - | $ 546 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
6.95 | - | - | $ 789 M | USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
11 | $ 12.67 | -9.24 % | $ 1.92 B | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alnylam Pharmaceuticals
ALNY
|
51.7 | $ 321.51 | -2.03 % | $ 42.1 B | USA |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
Cara Therapeutics
CARA
|
0.949 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
0.00635 | - | - | $ 3.74 B | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
0.774 | $ 1.09 | - | $ 22.4 M | Israel |
 |
Enochian Biosciences
ENOB
|
-5.41 | - | - | $ 40.5 M | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Equillium
EQ
|
4.13 | $ 1.91 | -7.28 % | $ 109 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 19.46 | -0.36 % | $ 910 M | USA |
 |
Amarin Corporation plc
AMRN
|
12.6 | $ 14.23 | -2.97 % | $ 5.91 B |  Irlanda |
 |
Bellerophon Therapeutics
BLPH
|
31 | - | -74.18 % | $ 955 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
2.28 | $ 45.99 | -3.28 % | $ 4.14 B |  Schweiz |
 |
Arbutus Biopharma Corporation
ABUS
|
11.1 | $ 4.33 | -2.81 % | $ 830 M | Canada |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.98 | - | - | $ 384 M | Britain |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |